Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Pipeline

Everest Medicines has appointed two veteran mRNA cancer vaccine scientists to strengthen its global clinical development pipeline. The move reflects growing international momentum in mRNA oncology applications, with the Asia-Pacific-focused biopharma positioning itself to accelerate cancer vaccine candidates through clinical stages.